HRH Prince Salman hails Bahrain-Sinopharm cooperation | THE DAILY TRIBUNE | KINGDOM OF BAHRAIN

HRH Prince Salman hails Bahrain-Sinopharm cooperation

TDT | Manama                        

The Daily Tribune –  

His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister, has commended the existing cooperation between Bahrain and Sinopharm in healthcare, as part of the ongoing efforts to serve humanity and ensure the health and safety of all.

HRH Prince Salman also expressed appreciation for the cooperation between Bahrain and Sinopharm, highlighting the Kingdom’s participation in phase-III anti-virus clinical trials in cooperation with Abu Dhabi-based artificial intelligence and Cloud Computing company, Group 42 (G42), which were conducted in the United Arab Emirates and the People’s Republic of China.

His Royal Highness was speaking as he met yesterday with the Chairman of China National Pharmaceutical Group Corporation (Sinopharm), Liu Jingzhen, at Gudaibiya Palace. HRH the Crown Prince and Prime Minister highlighted the importance of internationally coordinated efforts to meet global health challenges, noting the Kingdom’s commitment to supporting initiatives to safeguard global health security.

He reiterated Bahrain’s commitment to furthering coordination with relevant authorities and companies in the healthcare and treatment sector to achieve common aspirations. Liu expressed his appreciation for His Royal Highness’ support of international cooperation in health affairs.

He also thanked Bahrain for its constructive cooperation in promoting the health and greater good of and wished Bahrain further progress and prosperity. The Minister of Finance and National Economy, HE Shaikh Salman bin Khalifa Al Khalifa, and the Minister of Cabinet Affairs, HE Hamad bin Faisal Al Malki, also attended the meeting.